These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7585323)

  • 1. Pathophysiology of smooth muscle in hypertension.
    Lee RM; Owens GK; Scott-Burden T; Head RJ; Mulvany MJ; Schiffrin EL
    Can J Physiol Pharmacol; 1995 May; 73(5):574-84. PubMed ID: 7585323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blood vessel as a target organ in hypertension: protective effect of perindopril.
    Plante GE
    Can J Cardiol; 1994 Nov; 10 Suppl D():25D-29D. PubMed ID: 7954036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
    Ruschitzka FT; Lüscher TF
    Am Heart J; 1997 Aug; 134(2 Pt 2):S31-47. PubMed ID: 9313622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular hypertrophy in hypertension: role of the renin-angiotensin system.
    Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):108-17. PubMed ID: 9520514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related differences and roles of endothelial nitric oxide and prostanoids in angiotensin II responses of isolated, perfused mesenteric arteries and veins of rats.
    Konishi C; Naito Y; Saito Y; Ohara N; Ono H
    Eur J Pharmacol; 1997 Feb; 320(2-3):175-81. PubMed ID: 9059851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of peptide vasoconstrictors on vessel structure.
    Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
    Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial control of vascular tone and growth.
    Lüscher TF
    Clin Exp Hypertens A; 1990; 12(5):897-902. PubMed ID: 2208757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of cyclo-oxygenase products and NO in responses to angiotensin II of resistance arteries from the spontaneously hypertensive rat.
    Côrtes SF; Andriantsitohaina R; Stoclet JC
    Br J Pharmacol; 1996 Dec; 119(8):1635-41. PubMed ID: 8982512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin system and vascular hypertrophy.
    Rosendorff C
    J Am Coll Cardiol; 1996 Oct; 28(4):803-12. PubMed ID: 8837552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular remodeling: the role of angiotensin-converting enzyme inhibitors.
    Chrysant SG
    Am Heart J; 1998 Feb; 135(2 Pt 2):S21-30. PubMed ID: 9488609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes.
    Dzau VJ
    Curr Opin Nephrol Hypertens; 1993 Jan; 2(1):27-32. PubMed ID: 7922163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
    Schiffrin EL
    Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.
    Rajagopalan S; Kurz S; Münzel T; Tarpey M; Freeman BA; Griendling KK; Harrison DG
    J Clin Invest; 1996 Apr; 97(8):1916-23. PubMed ID: 8621776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antihypertensive treatment on small artery remodeling in hypertension.
    Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):168-76. PubMed ID: 12710531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin inhibits mesenteric vascular hypertrophy in angiotensin II-infusion hypertension in rats.
    Dilley RJ; Nataatmadja MI
    Cardiovasc Res; 1998 Apr; 38(1):247-55. PubMed ID: 9683928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries.
    Itoh T; Kajikuri J; Tada T; Suzuki Y; Mabuchi Y
    J Physiol; 2003 May; 548(Pt 3):893-906. PubMed ID: 12651915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
    Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endothelium in coronary artery disease.
    Ruschitzka FT; Noll G; Lüscher TF
    Cardiology; 1997; 88 Suppl 3():3-19. PubMed ID: 9397288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II.
    Touyz RM
    Exp Physiol; 2005 Jul; 90(4):449-55. PubMed ID: 15890798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance control in hypertension.
    Korner PI; Bobik A; Angus JA; Adams MA; Friberg P
    J Hypertens Suppl; 1989 Sep; 7(4):S125-34; discussion S135. PubMed ID: 2681590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.